No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference
Immunome President Acquires 24% More Stock
Immunome Insider Bought Shares Worth $962,181, According to a Recent SEC Filing
Immunome CEO Clay Siegall Acquires $962,181 in Company Stock